Patents by Inventor Kathleen Z. Reape

Kathleen Z. Reape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
    Patent number: 8450299
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: May 28, 2013
    Assignee: Teva Womans's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
    Patent number: 8415332
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: April 9, 2013
    Assignee: Teva Woman's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
    Publication number: 20120252767
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: June 8, 2012
    Publication date: October 4, 2012
    Applicant: Teva Women's Health, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION
    Publication number: 20110124611
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: October 26, 2010
    Publication date: May 26, 2011
    Applicant: TEVA WOMEN'S HEALTH, INC.
    Inventors: ROBERT G. BELL, CAROLE S. BEN-MAIMON, BEATA ISKOLD, LANCE J. BRONNENKANT, HOWARD HAIT, KATHLEEN Z. REAPE
  • Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
    Patent number: 7855190
    Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 21, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Robert G. Bell, Carole S. Ben-Maimon, Beata Iskold, Lance J. Bronnenkant, Howard Hait, Kathleen Z. Reape
  • Methods of hormonal treatment utilizing extended cycle contraceptive regimens
    Patent number: 7772219
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: August 10, 2010
    Assignee: Teva Women's Health, Inc.
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant
  • Regimens for Treatment of Conditions Related to Estrogen Deficiency
    Publication number: 20090247493
    Abstract: The present invention relates to methods of stimulating estrogen production that can be used to treat peri-menopausal or estrogen deficiency conditions utilizing regimens involving administration of estrogen and progestin, followed by a hormone-free period.
    Type: Application
    Filed: January 29, 2007
    Publication date: October 1, 2009
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape
  • Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
    Publication number: 20080125402
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: August 17, 2007
    Publication date: May 29, 2008
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles E. Diliberti, Kathleen Z. Reape, Lance J. Bronnenkant
  • Methods of hormonal treatment utilizing extended cycle contraceptive regimens
    Publication number: 20040220152
    Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
    Type: Application
    Filed: May 3, 2004
    Publication date: November 4, 2004
    Inventors: Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant